As of May 2024 Pacific Biosciences has a market cap of $0.60 Billion. This makes Pacific Biosciences the world's 5813th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.60 B | -76.85% |
2023 | $2.62 B | 41.85% |
2022 | $1.84 B | -59.02% |
2021 | $4.51 B | -7.07% |
2020 | $4.85 B | 517.07% |
2019 | $0.78 B | -29.21% |
2018 | $1.11 B | 262.27% |
2017 | $0.30 B | -12.83% |
2016 | $0.35 B | -66.48% |
2015 | $1.05 B | 81.19% |
2014 | $0.57 B | 67.21% |
2013 | $0.34 B | 262.99% |
2012 | $95.48 M | -37.78% |
2011 | $0.15 B | -81.75% |
2010 | $0.84 B |
On May 14th, 2024 the market cap of Pacific Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $227.04 B | 37,282.60% | ๐บ๐ธ USA |
General Electric GE | $175.13 B | 28,736.17% | ๐บ๐ธ USA |
Illumina ILMN | $18.41 B | 2,931.49% | ๐บ๐ธ USA |
PerkinElmer
PKI | $14.45 B | 2,280.13% | ๐บ๐ธ USA |
Luminex LMNX | $1.75 B | 188.16% | ๐บ๐ธ USA |
NanoString Technologies NSTG | $5.06 M | -99.17% | ๐บ๐ธ USA |